ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

May 3, 2002

Texas Cancer Plan Features Big Hike in Cigarette Tax

September 19, 1986

ACS President Calls On Physicians To Take Advantage Of “Untapped Opportunities” In Cancer Prevention

March 27, 1987

ACC Will Develop Standards, Patient Management Guidelines To Upgrade Community Cancer Programs

March 23, 1984

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

In Brief: Staff, Subcommittee Reports Due At NCAB June Meet; CCIRC to Sponsor Symposium On Epidemiology On Oct.

June 6, 1975